News
Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited because they require injection. Herein, we describe the discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results